Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 5024Carcinoma, Renal Cell 1577Urinary Bladder Neoplasms 1279Kidney Neoplasms 724Breast Neoplasms 643Neoplasms 630Carcinoma, Transitional Cell 490Carcinoma, Non-Small-Cell Lung 469Neoplasm Metastasis 468Melanoma 422Ovarian Neoplasms 401Colorectal Neoplasms 373Lung Neoplasms 333Pancreatic Neoplasms 262Sarcoma 233Stomach Neoplasms 227Uterine Cervical Neoplasms 225Testicular Neoplasms 216Non-Muscle Invasive Bladder Neoplasms 215Head and Neck Neoplasms 192Squamous Cell Carcinoma of Head and Neck 189Colonic Neoplasms 167Carcinoma, Hepatocellular 167Esophageal Neoplasms 165Endometrial Neoplasms 165Wilms Tumor 159Recurrence 131Triple Negative Breast Neoplasms 130Small Cell Lung Carcinoma 127Neuroblastoma 127

Interventions

tislelizumab 1pamiparib 1TNFeraseBiologic 1Injections 1Gefitinib 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Prostate Cancer × Genitourinary × Clear all
NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
40 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT01048151 2012-03-12

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

GenVec

Phase 1 Unknown
20 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT00319787 2011-01-25

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

AstraZeneca

Phase 2 Completed
102 enrolled
Genitourinary

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡